Regulation of the Chemokine Receptor CXCR4 by Hypoxia

Journal of Experimental Medicine

Volumn 198, Issue 9, 2003, Pages 1391-1402

  Schioppa, Tiziana ^a   Uranchimeg, Badarch ^e   Saccani, Alessandra ^a   Biswas, Subhra K ^a   Doni, Andrea ^a   Rapisarda, Annamaria ^e   Bernasconi, Sergio ^a   Saccani, Simona ^c   Nebuloni, Manuela ^d   Vago, Luca ^d   Mantovani, Alberto ^a,b   Melillo, Giovanni ^e   Sica, Antonio ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c INSTITUTE FOR RESEARCH IN BIOMEDICINE   (Switzerland)

^d UNIVERSITY OF MILAN   (Italy)

^e NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cell migration; Hypoxia inducible factor 1 (HIF 1); Low oxygen concentration; SDF 1 CXCL12 receptor (CXCR4)

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; HYPOXIA INDUCIBLE FACTOR 1ALPHA; STROMAL CELL DERIVED FACTOR 1;

ADAPTATION; ANGIOGENESIS; ANIMAL CELL; ARTICLE; CANCER CELL; CELL MIGRATION; CHEMOTAXIS; ENDOTHELIUM CELL; GENE EXPRESSION; GLYCOLYSIS; HUMAN; HUMAN CELL; HYPOXEMIA; HYPOXIA; MACROPHAGE; MONOCYTE; NONHUMAN; NORMAL HUMAN; OXYGEN CONCENTRATION; PRIORITY JOURNAL; TRANSCRIPTION REGULATION; TUMOR ASSOCIATED LEUKOCYTE;

ANIMALS; BASE SEQUENCE; CELL HYPOXIA; CELLS, CULTURED; DNA PRIMERS; ENDOTHELIUM, VASCULAR; HUMANS; MICE; PHAGOCYTES; RECEPTORS, CXCR4; RNA, MESSENGER;

EID: 10744219598     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20030267     Document Type: Article

References (55)

1. Semenza, G.L. 2001. Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology. Trends Mol. Med. 7:345-350.
2. Semenza, G.L. 1999. Perspectives on oxygen sensing. Cell. 98:281-284.
3. Wang, G.L., B.H. Jiang, E.A. Rue, and G.L. Semenza. 1995. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc. Natl. Acad. Sci. USA. 92:5510-5514.
4. Grimshaw, M.J., and F.R. Balkwill. 2001. Inhibition of monocyte and macrophage chemotaxis by hypoxia and inflammation - a potential mechanism. Eur. J. Immunol. 31:480-489.
5. Turner, L., C. Scotton, R. Negus, and F. Balkwill. 1999. Hypoxia inhibits macrophage migration. Eur. J. Immunol. 29:2280-2287.
6. Baggiolini, M. 1998. Chemokines and leukocyte traffic. Nature. 392:565-568.
7. Hedrick, J.A., and A. Zlotnik. 1996. Chemokines and lymphocyte biology. Curr. Opin. Immunol. 8:343-347.
8. Rollins, B.J. 1997. Chemokines. Blood. 90:909-928.
9. Murphy, P.M. 2002. International Union of Pharmacology. XXX. Update on chemokine receptor nomenclature. Pharmacol. Rev. 54:227-229.
10. Sica, A., A. Saccani, A. Borsatti, C.A. Power, T.N. Wells, W. Luini, N. Polentarutti, S. Sozzani, and A. Mantovani. 1997. Bacterial lipopolysaccharide rapidly inhibits expression of C-C chemokine receptors in human monocytes. J. Exp. Med. 185:969-974.
11. Sica, A., A. Saccani, B. Bottazzi, S. Bernasconi, P. Allavena, B. Gaetano, F. Fei, G. LaRosa, C. Scotton, F. Balkwill, and A. Mantovani. 2000. Defective expression of the monocyte chemotactic protein-1 receptor CCR2 in macrophages associated with human ovarian carcinoma. J. Immunol. 164:733-738.
12. Sica, A., A. Saccani, and A. Mantovani. 2002. Tumor-associated macrophages: a molecular perspective. Int. Immunopharmacol. 2:1045-1054.
13. Mantovani, A. 1999. The chemokine system: redundancy for robust outputs. Immunol. Today. 20:254-257.
14. Madjdpour, C., U.R. Jewell, S. Kneller, U. Ziegler, R. Schwendener, C. Booy, L. Klausli, T. Pasch, R.C. Schimmer, and B. Beck-Schimmer. 2003. Decreased alveolar oxygen induces lung inflammation. Am. J. Physiol. Lung Cell. Mol. Physiol. 284:360-367.
15. Mapp, P.I., M.C. Grootveld, and D.R. Blake. 1995. Hypoxia, oxidative stress and rheumatoid arthritis. Br. Med. Bull. 51:419-436.
16. Semenza, G.L. 2002. HIF-1 and tumor progression: pathophysiology and therapeutics. Trends Mol. Med. 8:S62-S67.
17. Mantovani, A., B. Bottazzi, F. Colotta, S. Sozzani, and L. Ruco. 1992. The origin and function of tumor-associated macrophages. Immunol. Today. 13:265-270.
18. Mantovani, A., S. Sozzani, M. Locati, P. Allavena, and A. Sica. 2002. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 23:549-555.
19. Leek, R.D., C.E. Lewis, R. Whitehouse, M. Greenall, J. Clarke, and A.L. Harris. 1996. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res. 56:4625-4629.
20. Leek, R.D., R.J. Landers, A.L. Harris, and C.E. Lewis. 1999. Necrosis correlates with high vascular density and focal macrophage infiltration with angiogenesis and prognosis in invasive carcinoma of the breast. Br. J. Cancer. 79:991-995.
21. Mantovani, A., V. Caprioli, P. Gritti, and F. Spreafico. 1977. Human mature macrophages mediate antybody-dependent cellular cytotoxicity on tumor cells. Transplantation. 24:291-293.
22. Romano, M., M. Sironi, C. Toniatti, N. Polentarutti, P. Fruscella, P. Ghezzi, R. Faggioni, W. Luini, V. van Hinsbergh, S. Sozzani, et al. 1997. Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity. 6:315-325.
23. Ivanov, S.V., I. Kuzmin, M.H. Wei, S. Pack, L. Geil, B.E. Johnson, E.J. Stanbridge, and M.I. Lerman. 1998. Downregulation of transmembrane carbonic anhydrases in renal cell carcinoma cell lines by wild-type von Hippel-Lindau transgenes. Proc. Natl. Acad. Sci. USA. 95:12596-12601.
24. Scotton, C.J., J.L. Wilson, D. Milliken, G. Stamp, and F.R. Balkwill. 2001. Epithelial cancer cell migration: a role for chemokine receptors? Cancer Res. 61:4961-4965.
25. Colotta, F., F. Bussolino, N. Polentarutti, A. Guglielmetti, M. Sironi, E. Bocchietto, M. De Rossi, and A. Mantovani. 1993. Differential expression of the common b and specific a chains of the receptors for GM-CSF, IL-3, and IL-5 in endothelial cells. Exp. Cell Res. 206:311-317.
26. Melillo, G., T. Musso, A. Sica, L.S. Taylor, G.W. Cox, and L. Varesio. 1995. A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter. J. Exp. Med. 182:1683-1693.
27. Caruz, A., M. Samsom, J.M. Alonso, J. Alcami, F. Baleux, J.L. Virelizier, M. Parmentier, and F. Arenzana-Seisdedos. 1998. Genomic organization and promoter characterization of human CXCR4 gene. FEBS Lett. 426:271-278.
28. Huang, E., J.M. Gu, M. Schau, and H.F. Bunn. 1998. Regulation of hypoxia-inducible factor 1 is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc. Natl. Acad. Sci. USA. 95:7987-7992.
29. Saccani, S., S. Pantano, and G. Natoli. 2002. p38-Dependent marking of inflammatory genes for increased NF-kappa B recruitment. Nat. Immmunol. 3:69-75.
30. Wang, G.L., and G.L. Semenza. 1993. Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: implications for models of hypoxia signal transduction. Blood. 82:3610-3615.
31. Salcedo, R., K. Wasserman, H.A. Young, M.C. Grimm, O.M. Howard, M.R. Anver, H.K. Kleinman, W.J. Murphy, and J.J. Oppenheim. 1999. Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: in vivo neovascularization induced by stromal-derived factor-1alpha. Am. J. Pathol. 154:1125-1135.
32. Nagasawa, T., S. Hirota, K. Tachibana, N. Takakura, S. Nishikawa, Y. Kitamura, N. Yoshida, H. Kikutani, and T. Kishimoto. 1996. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature. 382:635-638.
33. Muller, A., B. Homey, H. Soto, N. Ge, D. Catron, M.E. Buchanan, T. McClanahan, E. Murphy, W. Yuan, S.N. Wagner, et al. 2001. Involvement of chemokine receptors in breast cancer metastasis. Nature. 410:50-56.
34. Hon, W.C., M.I. Wilson, K. Harlos, T.D. Claridge, C.J. Schofield, C.W. Pugh, P.H. Maxwell, P.J. Ratcliffe, D.I. Stuart, and E.Y. Jones. 2002. Structural basis for the recognition of hydroxyproline in HIF-1 alpha by pVHL. Nature. 417:975-978.
35. Min, J.H., H. Yang, M. Ivan, F. Gertler, W.G. Jr. Kaelin, and N.P. Pavletich. 2002. Structure of an HIF-1alpha-pVHL complex: hydroxyproline recognition in signaling. Science. 296:1886-1889.
36. Lieubeau-Teillet, B., J. Rak, S. Jothy, O. Iliopoulos, W. Kaelin, and R.S. Kerbel. 1998. von Hippel-Lindau genemediated growth suppression and induction of differentiation in renal cell carcinoma cells grown as multicellular tumor spheroids. Cancer Res. 58:4957-4962.
37. Stratman, R., M. Krieg, R. Haas, and K.H. Plate. 1997. Putative control of angiogenesis in hemangioblastomas by the von Hippel-Lindau tumor supressor gene. J. Neuropathol. Exp. Neurol. 56:1142-1152.
38. Rapisarda, A., B. Uranchimeg, D.A. Scudiero, M. Selby, E.A. Sausville, R.H. Shoemaker, and G. Melillo. 2002. Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway. Cancer Res. 62:4316-4324.
39. Liew, F.Y., and I.B. McInnes. 2002. The role of innate mediators in inflammatory response. Mol. Immunol. 38:887-890.
40. Blake, D.R., P.G. Winyard, and R. Marok. 1994. The contribution of hypoxia-reperfusion injury to inflammatory synovitis: the influence of reactive oxygen intermediates on the transcriptional control of inflammation. Ann. NY Acad. Sci. 723:308-317.
41. Cernanec, J., F. Guilak, J.B. Weinberg, D.S. Pisetsky, and B. Fermor. 2002. Influence of hypoxia and reoxygenation on cytokine-induced production of proinflammatory mediators in articular cartilage. Arthritis Rheum. 46:968-975.
42. Gerard, C., and B.J. Rollins. 2001. Chemokines and disease. Nat. Immunol. 2:108-115.
43. Cramer, T., Y. Yamanishi, B.E. Clausen, I. Forster, R. Pawlinski, N. Mackman, V.H. Haase, R. Jaenisch, M. Corr, V. Nizet, et al. 2003. HIF-1alpha is essential for myeloid cell-mediated inflammation. Cell. 112:645-657.
44. Foxman, E.F., J.J. Campbell, and E.C. Butcher. 1997. Multistep navigation and the combinatorial control of leukocyte chemotaxis. J. Cell Biol. 139:1349-1360.
45. Folkman, J. 1995. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1:27-31.
46. Hanahan, D., and J. Folkman. 1996. Patterns of emerging mechanisms of the angiogenic switch during tumongenesis. Cell. 86:353-364.
47. Crowther, M., N.J. Brown, E.T. Bishop, and C.E. Lewis. 2001. Microenvironmental influence on macrophage regulation of angiogenesis in wounds and malignant tumors. J. Leukoc. Biol. 70:478-490.
48. Hirani, N., F. Antonicelli, R.M. Strieter, M.S. Wiesener, P.J. Ratcliffe, C. Haslett, and S.C. Donnelly. 2001. The regulation of interleukin-8 by hypoxia in human macrophage-a potential role in the pathogenesis of the Acute Respiratory Distress Syndrome (ARDS). Mol. Med. 10:685-697.
49. Payne, A.S., and L.A. Cornelius. 2002. The role of chemokines in melanoma tumor growth and metastasis. J. Invest. Dermatol. 118:915-922.
50. Nagasawa, T. 2001. Role of chemokine SDF-1/PBSF and its receptor CXCR4 in blood vessel development. Ann. NY Acad. Sci. 947:112-115.
51. Strieter, R.M., P.J. Polverini, D.A. Arenberg, and S.L. Kunkel. 1995. The role of CXC chemokines as regulators of angiogenesis. Shock. 4:155-160.
52. Liotta L.A. 2001. An attractive force in metastasis. Nature. 410:24-25.
53. Aoudjit, F., E.F. Potworowski, and Y. St-Pierre. 1998. The metastatic characteristics of murine lymphoma cell lines in vivo are manifested after target organ invasion. Blood. 91:623-629.
54. Krishnamachary, B., S. Berg-Dixon, B. Kelly, F. Agani, D. Feldser, G. Ferreira, N. Iyer, J. LaRusch, B. Pak, P. Taghavi, and G.L. Semenza. 2003. Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1. Cancer Res. 63:1138-1143.
55. Pugh, C.W., and P.J. Ratcliffe. 2003. The von Hippel-Lindau tumor suppressor, hypoxia-inducible factor-1 (HIF-1) degradation, and cancer pathogenesis. Semin. Cancer Biol. 13:83-89.